Ceribell Secures FDA Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Shots: The US FDA has granted 510(k) clearance to a new software for the Ceribell System that converts raw EEG information into simplified easy-to-read trends, helping clinicians monitor changes in brain activity  The update adds Alpha-Delta Ratio & Relative Alpha trending for detecting early signs of brain distress & reduced blood flow in high-risk pts, Burst Suppression monitoring to support sedation management, & Amplitude-Integrated EEG (aEEG) for long-term monitoring of background brain activity The clearance has no age restriction, enabling the same easy-to-use trends from premature newborns to adults. Ceribell expects to deliver the features through an automatic software update in H1’27 Ref: Ceribell |   Image: Ceribell  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ceribell Secures FDA Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis appeared first on PharmaShots.